REGENXBIO Inc. Adjustments to Additional Paid in Capital, Warrant Issued
REGENXBIO Inc. (RGNX) reported Adjustments to Additional Paid in Capital, Warrant Issued of $1.61 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2026-08-06
- REGENXBIO Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2025-12-31 was $0.00.
- REGENXBIO Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2025-09-30 was $0.00.
- REGENXBIO Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2025-06-30 was $1.61M.
- REGENXBIO Inc. adjustments to additional paid in capital, warrant issued for fiscal 2025 was $1.61M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 9 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $0.00 derived: sum of 2 quarters · filed 2026-03-05 | $1.61M derived: sum of 3 quarters · filed 2026-08-06 | $1.61M 10-K · filed 2026-03-05 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $1.61M derived: sum of 2 quarters · filed 2026-08-06 | $1.61M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $1.61M 10-Q · filed 2026-08-06 | $1.61M 10-Q · filed 2026-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |